Literature DB >> 28493578

Internal radionuclide therapy: The ULMDOS software for treatment planning.

Gerhard Glatting1, Michael Landmann1, Thomas Kull1, Arthur Wunderlich2, Norbert M Blumstein1, Andreas K Buck1, Sven N Reske1.   

Abstract

Before therapy with unsealed radionuclides, a dosimetry assessment must be performed for each patient. We present the interactive software tool ULMDOS, which facilitates dosimetric calculations, enhances traceability, and adequate documentation. ULMDOS is developed in IDL 6.1 (Interactive Data Language) under Windows XP/2000. First the patient data, the radiotracer data, and optionally urine and serum data are entered. After loading planar gamma camera images and drawing regions of interest, the residence times can be calculated using fits of the time activity data to exponential functions. Data can be saved in ASCII format for retrospective examination and further processing. ULMDOS allows one to process the dosimetric calculations within a standardized environment, spares the time-consuming transfer of data between different software tools, enables the documentation of ROI and raw data, and reduces intraindividual variability. ULMDOS satisfies the required conditions for traceability and documentation as a prerequisite to routine use in clinical settings.
© 2005 American Association of Physicists in Medicine.

Entities:  

Keywords:  Anatomy; Cameras; Computational models; Computer software; Dosimetry; Gamma rays; Medical imaging; Radioactivity; Radiopharmaceuticals; Time measurement; Treatment strategy; dosimetry; medical computing; radiation therapy; radionuclide therapy; residence time; treatment planning

Year:  2005        PMID: 28493578     DOI: 10.1118/1.1945348

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  1 in total

1.  Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND).

Authors:  Eric Visser; Ernst Postema; Otto Boerman; Jeroen Visschers; Wim Oyen; Frans Corstens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-15       Impact factor: 9.236

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.